Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 257 in our database
Found 1977 in our records

HQ: North Chicago, Illinois, United States
AbbVie is a pharmaceutical company that discovers,Show more... develops, and markets medicines.
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
Main email format: sarah.smith@abbvie.com (59.3%)
-
Richard A Gonzalez
r**************z@abbvie.com
-
Jonathan Pound
Sr Specialty Representative
j************d@abbvie.com
-
Andrew Dillard
a************d@abbvie.com
-
Jennifer Langan
j*************n@abbvie.com
-
Jay Stamatis
j**********s@abbvie.com
-
Miki Mancine
m**********e@abbvie.com
-
Catherine Desjardins
Regional Manager, Market Access and Government Affairs in Oncology
c******************s@abbvie.com
-
Felix J Gonzalezreyes
f*****************s@abbvie.com
-
Ateet Shah
a********h@abbvie.com
-
Robert Michael
President and Chief Operating Officer
r****t@abbvie.com
-
Tim Hale
t******e@abbvie.com
-
Kumar Kantheti
Head of Customer Insights at Regeneron Pharmaceuticals, Inc.
k************i@abbvie.com
-
Alfonso Savoia
a************a@abbvie.com
-
Marie-Charlotte GOFF
m*******************f@abbvie.com
-
Carrie Strom
Senior Vice President, US Medical Aesthetics
c**********m@abbvie.com
-
Glen Curran
Vice President, Marketing, US Eyecare
g*********n@abbvie.com
-
Jessica Campagna
Director, Regulatory Affairs
j**************a@abbvie.com
-
Natalie Anderten
Director, Clinical Development Operations
n**************n@abbvie.com
-
Gamal Ferrer
Supply Planning Manager
g**********r@abbvie.com
-
Alex Selsky
a*********y@abbvie.com
-
Bill Pappano
b**********o@abbvie.com
-
Laurence Pierard
l**************d@abbvie.com
-
Jane Woo
j******o@abbvie.com
-
Liz Lloyd
l*******d@abbvie.com
-
Francescaeugenia Civardi
f**********************i@abbvie.com
-
Eric Nelson
e*********n@abbvie.com
-
Hanne Vanspaendonk
h****************k@abbvie.com
-
Jacob Degner
j**********r@abbvie.com
-
Nestor Ortiz
n**********z@abbvie.com
-
Philip Mcquain
p************n@abbvie.com
-
Tamar Uziel
t*********l@abbvie.com
-
Jill Hoeger
j*********r@abbvie.com
-
Ahmed Othman
a**********n@abbvie.com
-
Earle Bain
e********n@abbvie.com
-
Lisa Greenstein
l*************n@abbvie.com
-
Samrat Mukherjee
s**************e@abbvie.com
-
Lloyd Lam
l*******m@abbvie.com
-
Joshua Plotnik
j************k@abbvie.com
-
Stephen Fortino
s*************o@abbvie.com
-
Robert A Love
r***********e@abbvie.com
-
Tino Seidel
t*********l@abbvie.com
-
John Engelhardt
j*************t@abbvie.com
-
Mk Steel
m******l@abbvie.com
-
Carlos Taveras
c************s@abbvie.com
-
Jens Herrfurth
j************h@abbvie.com
-
Carola Vogt
c*********t@abbvie.com
-
Ariel Ting
a********g@abbvie.com
-
Anja Moeller
a**********r@abbvie.com
-
Scott Filarski
s************i@abbvie.com
-
Joachim Vogt
j**********t@abbvie.com
-
Josue Samayoa
j***********a@abbvie.com
-
Krystal Loewe
k***********e@abbvie.com
-
Jan Lohne
j*******e@abbvie.com
-
Bei Chen
b******n@abbvie.com
-
Francesca Marrani
f***************i@abbvie.com
-
Silvija Vaitkiene
s***************e@abbvie.com
-
Thorsten Pflanzner
t****************r@abbvie.com
-
Sara Orndoff
s**********f@abbvie.com
-
Antonis Papasolomontos
a********************s@abbvie.com
-
Philipp Huwe
p**********e@abbvie.com
-
Krystal Bruno
k***********o@abbvie.com
-
Lisa Miller
l*********r@abbvie.com
-
Erica Gruvberg
e************g@abbvie.com
-
Lavina Harjani
l************i@abbvie.com
-
Andrew D Vogt
a***********t@abbvie.com
-
Meri Oliva
m********a@abbvie.com
-
Mariadelcarmen Estrada
m********************a@abbvie.com
-
Elena Dianova
e***********a@abbvie.com
-
Dawn George
d*********e@abbvie.com
-
Kent Pearson
k**********n@abbvie.com
-
Kei Takatsu
k*********u@abbvie.com
-
Johannes Huelsenbeck
j******************k@abbvie.com
-
Shunya Urata
s**********a@abbvie.com
-
Sebastian Koob
s************b@abbvie.com
-
Paul E Kroeger
p************r@abbvie.com
-
Be Mnp
b****p@abbvie.com
-
Christopher Kwok
c**************k@abbvie.com
-
Brendan Mccarthysinclair
b**********************r@abbvie.com
-
Margaret Fettiskoenders
m*********************s@abbvie.com
-
Pv Saudiarabia
p************a@abbvie.com
-
Carleigh Kmetz
c************z@abbvie.com
-
Ed Reilly
e*******y@abbvie.com
-
Cyril Ramathal
c************l@abbvie.com
-
Xin X Lu
x******u@abbvie.com
-
Adrian Hobson
a***********n@abbvie.com
-
Jason Holbert
j***********t@abbvie.com
-
Susan Bale
s********e@abbvie.com
-
Cynthia Waseity
c*************y@abbvie.com
-
Michal Roszkowski
m***************i@abbvie.com
-
Mike Dennis
m*********s@abbvie.com
-
Robert Grundman
r*************n@abbvie.com
-
Sebastian Wachtarz
s****************z@abbvie.com
-
Michael R Robinson
m****************n@abbvie.com
-
Mansour Dughbaj
m*************j@abbvie.com
-
Yixin Fang
y********g@abbvie.com
-
Lisa Hazelwood
l************d@abbvie.com
-
Hannah Palac
h**********c@abbvie.com
-
Yu Deng
y*****g@abbvie.com
-
Elizabeth Shea
e************a@abbvie.com
-
Sarah Beck
s********k@abbvie.com
-
Natalie Bennett
n*************t@abbvie.com
-
Cheryl Pitcher
c************r@abbvie.com
-
Joanna Jones
j**********s@abbvie.com
-
Nancy Sever
n*********r@abbvie.com
-
Kim Hogan
k*******n@abbvie.com
-
David Maag
d********g@abbvie.com
-
Hetal Sarvaiya
h************a@abbvie.com
-
Yuki Koshi
y********i@abbvie.com
-
Stevan W Djuric
s*************c@abbvie.com
-
Hiroki Matsuo
h***********o@abbvie.com
-
Martha Titler
m***********r@abbvie.com
-
Alexandra Smith
a*************h@abbvie.com
-
Lauren Himmel
l***********l@abbvie.com
-
Forrest Weghorst
f**************t@abbvie.com
-
Nakesha Spellman
n**************n@abbvie.com
-
Parul Singh
p*********h@abbvie.com
-
Isheeta Shah
i**********h@abbvie.com
-
Christian Sanandres
c*****************s@abbvie.com
-
Anil Vasudevan
a************n@abbvie.com
-
Justin Rayyan
j***********n@abbvie.com
-
James Marek
j*********k@abbvie.com
-
Sophee Blanthornhazell
s********************l@abbvie.com
-
Rahul Mehta
r*********a@abbvie.com
-
Javier Leaniz
j***********z@abbvie.com
-
Jit Bhowmick
j**********k@abbvie.com
-
David Masica
d**********a@abbvie.com
-
Robert Mclaughlin
r***************n@abbvie.com
-
Anuj Verma
a********a@abbvie.com
-
Jianzhen Chan
j***********n@abbvie.com
-
Stephanie Weinstein
s*****************n@abbvie.com
-
Brian C Anderson
b**************n@abbvie.com
-
Karol Charkiewicz
k***************z@abbvie.com
-
Shawn Jeffries
s************s@abbvie.com
-
Stacy Sullivan
s************n@abbvie.com
-
Geoff Gz Zhang
g************g@abbvie.com
-
Namita Tundia
n***********a@abbvie.com
-
Sarah Doupe
s*********e@abbvie.com
-
Chris Medina
c**********a@abbvie.com
-
Takafumi Tanaka
t*************a@abbvie.com
-
Razaq Salau
r*********u@abbvie.com
-
Chelsea Parrocha
c**************a@abbvie.com
-
Jane Qian
j*******n@abbvie.com
-
Bryan Rogers
b**********s@abbvie.com
-
Michael Kaltschmidt
m*****************t@abbvie.com
-
Jeroen Schrevens
j**************s@abbvie.com
-
Jamie Chouinard
j*************d@abbvie.com
-
Jeffrey Waite
j***********e@abbvie.com
-
Jason Hart
j********t@abbvie.com
-
Jules Holland
j***********d@abbvie.com
-
Melvin Munsaka
m************a@abbvie.com
-
Namjin Chung
n**********g@abbvie.com
-
Ning Sun
n******n@abbvie.com
-
Edward Ronan
e**********n@abbvie.com
-
Niharika Chauhan
n**************n@abbvie.com
-
Lin Zhu
l*****u@abbvie.com
-
Anna Levi
a*******i@abbvie.com
-
Giuliana Gualberti
g****************i@abbvie.com
-
Naoki Wasa
n********a@abbvie.com
-
Zoltan Dezso
z**********o@abbvie.com
-
Reyhaneh Nazarian
r***************n@abbvie.com
-
Nam Bui
n*****i@abbvie.com
-
Dalila Miele
d**********e@abbvie.com
-
Keturah Kiper
k***********r@abbvie.com
-
Andrella King
a***********g@abbvie.com
-
Sana Khajehpour
s*************r@abbvie.com
-
Rebecca Kattan
r************n@abbvie.com
-
Jerry Jacob
j*********b@abbvie.com
-
Heather Huang
h***********g@abbvie.com
-
Catherine Ho
c**********o@abbvie.com
-
Melanie Flores
m************s@abbvie.com
-
Payal Bhatt
p*********t@abbvie.com
-
Laura Gasparini
l*************i@abbvie.com
-
Kartik Anne
k*********e@abbvie.com
-
Minna Abdelaziz
m*************z@abbvie.com
-
Josette Hughes
j************s@abbvie.com
-
Megan Jimerson
m************n@abbvie.com
-
Teresa K Oberlander
t*****************r@abbvie.com
-
Roland Heym
r*********m@abbvie.com
-
Aoi Kurano
a********o@abbvie.com
-
Jeff Onyskiw
j**********w@abbvie.com
-
Jodi Walker
j*********r@abbvie.com
-
Evgenyi Shalaev
e*************v@abbvie.com
-
Yunzhao Xing
y**********g@abbvie.com
-
Aparna Shinde
a***********e@abbvie.com
-
Leonie Hammer
l***********r@abbvie.com
-
Gregory Willocq
g*************q@abbvie.com
-
Bobbi Wiggins
b***********s@abbvie.com
-
Yoosook Kim
y*********m@abbvie.com
-
John Torrisi
j**********i@abbvie.com
-
Barbara Razenberg
b***************g@abbvie.com
-
Matthew Galley
m************y@abbvie.com
-
Emily King
e********g@abbvie.com
-
Gentry Lassiter
g*************r@abbvie.com
-
Elena Karpilovski
e***************i@abbvie.com
-
Liz Shea
l******a@abbvie.com
-
Ilke Limoncu
i**********u@abbvie.com
-
Alyssa Rege
a*********e@abbvie.com
-
Raquel Powers
r***********s@abbvie.com
-
Jeremy Picard
j***********d@abbvie.com
-
Adelle Infante
a************e@abbvie.com
-
Todd Bosse
t********e@abbvie.com
-
Joao N Belo
j*********o@abbvie.com
-
Jaquelin Finley
j*************y@abbvie.com
-
Gerlinde Baldauf
g**************f@abbvie.com
-
V Siparis
v*******s@abbvie.com
-
Jenna Hanson
j**********n@abbvie.com
-
David Wagner
d**********r@abbvie.com
-
Isabelle Petatthiolas
i*******************s@abbvie.com
-
Anisha Manix
a**********x@abbvie.com
-
Jacqueline Karis
j**************s@abbvie.com
-
Suzanne Barston
s*************n@abbvie.com
-
Shannelle Fowler
s**************r@abbvie.com
-
Dana Harville
d***********e@abbvie.com
-
Gabrielle Tarbert
g***************t@abbvie.com
-
Susanne Griffiths
s***************s@abbvie.com
-
Larry Peepo
l*********o@abbvie.com
-
Gregory Miley
g***********y@abbvie.com
-
Courtney Fella
c************a@abbvie.com
-
Jonathan Anderson
j***************n@abbvie.com
-
Jenina Nunez
j**********z@abbvie.com
-
Moiz Diwan
m********n@abbvie.com
-
Tym Lindsey
t*********y@abbvie.com
-
Office At
o*******t@abbvie.com
-
Mandie Judy
m*********y@abbvie.com
-
Fabio Lievano
f***********o@abbvie.com
-
Thao T Doan
t*********n@abbvie.com
-
Peter Bacher
p**********r@abbvie.com
-
Birgitta Bjornek
b**************k@abbvie.com
-
Joy Jacksonguilford
j******************d@abbvie.com
-
Rebecca Kohnken
r*************n@abbvie.com
-
Elizabeth Simms
e*************s@abbvie.com
-
Lucas Chavira
l***********a@abbvie.com
-
David Gardner
d***********r@abbvie.com
-
Juliapaige Yuhase
j***************e@abbvie.com
-
Fernando Bastos
f*************s@abbvie.com
-
Yunhao Tan
y********n@abbvie.com
-
Hongjian Zhu
h**********u@abbvie.com
-
Carlos Hader
c**********r@abbvie.com
-
Samira Mawla
s**********a@abbvie.com
-
Fabian Liboschik
f**************k@abbvie.com
-
Petra Grossmann
p*************n@abbvie.com
-
Anna Samokhvalova
a***************a@abbvie.com
-
Dai Feng
d******g@abbvie.com
-
Iain Boomer
i*********r@abbvie.com
-
Alice Chan
a********n@abbvie.com
-
Megana Vatson
m***********n@abbvie.com
-
Amanda Vogel
a**********l@abbvie.com
-
Jun Yu
j****u@abbvie.com
-
Kevin Zowaski
k***********i@abbvie.com
-
Eva Sebestova
e***********a@abbvie.com
-
Kathrin Kuntz
k***********z@abbvie.com
-
Brian Martin
b**********n@abbvie.com
-
Jijie Gu
j******u@abbvie.com
-
Andrew Shaw
a*********w@abbvie.com
-
Florian Dieckmann
f***************n@abbvie.com
-
David Freundel
d************l@abbvie.com
-
Javier Boix
j*********x@abbvie.com
-
Tamer Hanna
t*********a@abbvie.com
-
Diana L Donnellyroberts
d**********************s@abbvie.com
-
Dayoung Yi
d********i@abbvie.com
-
Renee Heuser
r**********r@abbvie.com
-
Blai Coll
b*******l@abbvie.com
-
Muriel Haraoui
m************i@abbvie.com
-
Daniela Haertel
d*************l@abbvie.com
-
Sanjay Bhardwaj
s*************j@abbvie.com
-
Kaisa Raitio
k**********o@abbvie.com
-
Sabine Grote
s**********e@abbvie.com
-
Johanna Castrillon
j****************n@abbvie.com
-
Veronique Paula
v*************a@abbvie.com
-
Christina Lee
c***********e@abbvie.com
-
Gary Chiang
g*********g@abbvie.com
-
Marketta Piskonen
m***************n@abbvie.com
-
Aman Thukral
a**********l@abbvie.com
-
Julie Lepsetz
j***********z@abbvie.com
-
Hannah Martinez
h*************z@abbvie.com
-
Aris Vasilopoulos
a***************s@abbvie.com
-
Ryota Watanabe
r************e@abbvie.com
-
Takao Nito
t********o@abbvie.com
-
Weili He
w******e@abbvie.com
-
Mabel Martinez
m************z@abbvie.com
-
Devin Slagle
d**********e@abbvie.com
-
Eileen Murphy
e***********y@abbvie.com
-
Giuseppina Zarigno
g****************o@abbvie.com
-
Eric Mohler
e*********r@abbvie.com
-
Min Zhang
m*******g@abbvie.com
-
Terhi Pellinen
t************n@abbvie.com
-
Anne Lejon
a********n@abbvie.com
-
Marcello Rinaldi
m**************i@abbvie.com
-
Ryoichi Kiyohara
r**************a@abbvie.com
-
Jillian Griffin
j*************n@abbvie.com
-
Shuai Hao
s*******o@abbvie.com
-
Jessica Feltman
j*************n@abbvie.com
-
Jeffrey Allan
j***********n@abbvie.com
-
Frank Benenati
f************i@abbvie.com
-
Shashank Shekhar
s**************r@abbvie.com
-
Roxann Stubbs
r***********s@abbvie.com
-
Medha Tomlinson
m*************n@abbvie.com
-
Beatriz Samanes
b*************s@abbvie.com
-
Kate Ferrario
k***********o@abbvie.com
-
Nicole Muraca
n***********a@abbvie.com
-
Jay Lucas
j*******s@abbvie.com
-
Helene Villeneuve
h***************e@abbvie.com
-
Pascal Marcoux
p************x@abbvie.com
-
Nathalie Lavoie
n*************e@abbvie.com
-
Theresia Bredenwall
t*****************l@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
talentacquisition@abbvie.com
-
Unclassified inbox
AbbvieCDO@abbvie.com
-
Unclassified inbox
privacydsr@abbvie.com
-
Unclassified inbox
info-cz@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
switzerland@abbvie.com
-
Unclassified inbox
orders@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
medical_info_spain@abbvie.com
-
Unclassified inbox
safety-cz@abbvie.com
-
Unclassified inbox
plsproductsurveillanceteam@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
hrconnect.northamerica@abbvie.com
-
Unclassified inbox
abbviepaa@abbvie.com
-
Unclassified inbox
managepd_support_it@abbvie.com
-
Unclassified inbox
library@abbvie.com
-
Unclassified inbox
job-opportunities@abbvie.com
-
Unclassified inbox
sp-assuntos_regulatorios@abbvie.com
-
Unclassified inbox
cs-germany@abbvie.com
-
Customer Service
service@abbvie.com
-
Unclassified inbox
info.de@abbvie.com

HQ: Rahway, New Jersey, United States
Merck is a biopharmaceutical company that offers mShow more...edicines and vaccines for various diseases.
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Main email format: sarah_smith@merck.com (76.9%)
-
Phillip Samayoa
Associate Director, MRL Ventures
p******s@merck.com
-
Lubomir Kamensky
l**************y@merck.com
-
Carolina Colella
c**************a@merck.com
-
Rachel Parise
PhD Candidate - Analytical Chemistry Reseacher
r***********e@merck.com
-
Peter Dudek
Associate
p*********k@merck.com
-
Marc Gailhardou
a VP Global Oncology Strategy at Merck
m*************u@merck.com
-
Jieyun Hao
HR Business Partner
j********o@merck.com
-
Francesca Poggio
f**************o@merck.com
-
Ken Friesen
k*********n@merck.com
-
Austin Snook
a**********k@merck.com
-
Roberta Corsi
r***********i@merck.com
-
Vishal Sahni
Venture Capital advisory committee member, Biofund II
v**********i@merck.com
-
John Minehane
Assistant Production Manager
j***********e@merck.com
-
Cheryl Donnelly
c*************y@merck.com
-
Courtney Ronaldo
c**************o@merck.com
-
Tracy Clemmer
t************2@merck.com
-
Harry Herar
Sales Representative
h*********r@merck.com
-
Andrei Manica
a***********a@merck.com
-
Sergey Zverev
s***********v@merck.com
-
Rehan A Khan
r********n@merck.com
-
Kevin Ali
k*******i@merck.com
-
Kevin Sharpe
k**********e@merck.com
-
Heather Rakestraw
h***************w@merck.com
-
Cedric Grand-Pierre
c****************e@merck.com
-
Joyce. Pennings
j************s@merck.com
-
Anneke Rietveld
Key Account Manager
a*************d@merck.com
-
Legal Department
legal@merck.com

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Main email format: sarah.smith@pfizer.com (92.1%)
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Main email format: sarah.smith@pfizer.com (92.1%)
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com

HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com

HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com

HQ: Whippany, New Jersey, United States
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com

HQ: Leverkusen, Nordrhein-Westfalen, Germany
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Leverkusen, Nordrhein-Westfalen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
Unclassified inbox
SCIP-BAYER@bayer.com
-
General Inquiries
info@bayer.com
-
Unclassified inbox
caio.inbox@bayer.com

HQ: Whippany, New Jersey, United States
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com

HQ: Cambridge, Cambridgeshire, United Kingdom
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com

HQ: Basel, Basel-Stadt, Switzerland
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
David Barton
d********1@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com

HQ: New York, New York, United States
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
General Inquiries
hello@bms.com
-
General Inquiries
contact@bms.com
-
Legal Department
legal@bms.com

HQ: London, England, United Kingdom
Johnson Matthey is an international speciality cheShow more...micals company, founded almost 200 years ago in London.
HQ: London, England, United Kingdom
Specialized In: Manufacturing & Industrial, Technology & Software, Pharmaceuticals, Staffing Agencies
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 20, 2024
Founded Date: 1817
Number of Exits: 1
Company Type: For Profit
Stock Symbol: LSE:JMPLF
Operating Status: Active
Main email format: sarah.smith@matthey.com (89.5%)
-
Margaret Ruiseal
Global HR Transformation Director
m**************l@matthey.com
-
David Colomina
ITIL Instructor
d************a@matthey.com
-
Sharmila Thirumalai
Technical Recruiter
s*****************i@matthey.com
-
Ekaterina Novakova
Market Manager Purification
e****************a@matthey.com
-
Aaron Bloomfield
Research And Development Scientist
a**************d@matthey.com
-
Rebecca Lawman
Marketing Director
r************n@matthey.com
-
David Nguyen
Human-centered Innovator/Entrepreneur/Researcher
n*****d@matthey.com
-
Ryan Mitstifer
Global Operational Excellence Leader
r************r@matthey.com
-
Jonathan Mccreegrey
Hydrogen Technologies Recycling Manager
jm@matthey.com
-
Joe Fox
Finance Transformation Director
j*****x@matthey.com
-
Randy Lerch
Night Shift Maintenance Supervisor
r*********h@matthey.com
-
Harry Deans
EHS & Operations Officer
h*********s@matthey.com
-
Karen Hayzen-Smith
Director of Group Finance
k****************h@matthey.com
-
Benedicte Thiebaut
Technology Director of Medical Components
b****************t@matthey.com
-
Percival Norton Johnson
Founder
j*****n@matthey.com
-
Unclassified inbox
elmar.braeuning@matthey.com
-
Unclassified inbox
mj@matthey.com
-
General Inquiries
group.info@matthey.com
-
Unclassified inbox
jmpr@matthey.com

HQ: Brentford, Hounslow, United Kingdom
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
HQ: Brentford, Hounslow, United Kingdom
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
Main email format: sarah.smith@gsk.com (93.8%)
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com

HQ: London, England, United Kingdom
GlaxoSmithKline develops and markets products in tShow more...he areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active
Main email format: sarah.smith@gsk.com (93.8%)
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
General Inquiries
info@gsk.com
-
Customer Service
support@gsk.com
-
Sales Department
sales@gsk.com
-
Unclassified inbox
Simon.M.Bicknell@gsk.com

HQ: Brentford, Hounslow, United Kingdom
GSK manufactures pharmaceutical medicines, vaccineShow more...s, and consumer healthcare products.
HQ: Brentford, Hounslow, United Kingdom
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 20, 2024
Founded Date: Jan 2000
Company Type: For Profit
Stock Symbol: BOM:500660
Operating Status: Active
Main email format: sarah.smith@gsk.com (93.8%)
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
Unclassified inbox
askus@gsk.com

HQ: San Francisco, California, United States
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu

HQ: San Francisco, California, United States
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu

HQ: Thousand Oaks, California, United States
Amgen is a biotechnology company that develops andShow more... manufactures human therapeutics for various illnesses and diseases.
HQ: Thousand Oaks, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active
Main email format: ssmith@amgen.com (88.9%)
-
Esteban Santos
Executive Vice President, Operations
e******s@amgen.com
-
Wendy Kusler
w*****r@amgen.com
-
Krupali Patel
k****l@amgen.com
-
Susan Sweeney
s******y@amgen.com
-
Angelinda Chen
Gender Lens Impact Investing Fellow
a***n@amgen.com
-
Daniel Lu
d*u@amgen.com
-
Rex Atienza
r******a@amgen.com
-
Unclassified inbox
HCCIME@amgen.com
-
Unclassified inbox
medinfocanada@amgen.com
-
Unclassified inbox
amgenmediarelations@amgen.com

HQ: Foster City, California, United States
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
HQ: Foster City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
Main email format: sarah.smith@gilead.com (82.4%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Unclassified inbox
public_affairs@gilead.com

HQ: Durham, North Carolina, United States
Quintiles is a provider of biopharmaceutical develShow more...opment and commercial outsourcing services for drugs on the market.
HQ: Durham, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active
Main email format: sarah.smith@quintiles.com (100.0%)
-
Brian Kelly
Senior Advisor
p************k@quintiles.com
-
Jara Soltero
j**********o@quintiles.com
-
Hicham Benhaddi
h*************i@quintiles.com
-
Alistair Grenfell
President North Europe, Middle East, Africa and South Asia
a***************l@quintiles.com
-
Diane Brescia
Sr. Recruiter
d***********a@quintiles.com
-
Parag Phad
p********d@quintiles.com
-
Michelle Wilken
Director of Commercial Strategy
m*************n@quintiles.com
-
Jeff Fusco
j********o@quintiles.com
-
Cindy Lam
c*******m@quintiles.com
-
Patrick Daly
Executive In Residence
p**********y@quintiles.com
-
Debalina Pani
d***********i@quintiles.com
-
Fatemeh Tahavori
fatemeh.tahavori@quintiles.com
-
General Inquiries
info@quintiles.com

HQ: Cambridge, Massachusetts, United States
Moderna Therapeutics is a biotechnology company thShow more...at specializes in drug discovery and drug development based on messenger RNA.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank
Main email format: sarah.smith@modernatx.com (100.0%)
-
Tatiana Novobrantseva
Chief Scientific Officer, Immuno-Oncology Research
t*******************a@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
j*********s@modernatx.com
-
Nidal El Assi
Associate Director Of Lab Operations
n********i@modernatx.com
-
Lavina Talukdar
l*************r@modernatx.com
-
Shannon Thyme Klinger
Chief Legal Officer at Moderna
s*************r@modernatx.com
-
Gamal Elfatarany
g**************y@modernatx.com
-
Unclassified inbox
WeCare@modernatx.com
-
Unclassified inbox
Grace.Chen@modernatx.com
-
General Inquiries
info@modernatx.com

HQ: Indianapolis, Indiana, United States
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jul 8, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com

HQ: Indianapolis, Indiana, United States
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 6, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com

HQ: Boston, Massachusetts, United States
Vertex Pharmaceuticals is focused on the discoveryShow more... and development of small molecule drugs for the treatment of serious diseases.
HQ: Boston, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
Main email format: sarah_smith@vrtx.com (64.3%)
-
Mark Yu
Senior Research Associate
m*****u@vrtx.com
-
Isaac Vasanthkumar
i****************r@vrtx.com
-
Guoxiang Ruan
g***********n@vrtx.com
-
Phillip Snyder
p************r@vrtx.com
-
Mac Johnson
Senior Director, Research, Vertex Pharmaceuticals
m*********n@vrtx.com
-
Morrey Atkinson
m*************n@vrtx.com
-
General Inquiries
mediainfo@vrtx.com

HQ: Tel Aviv, Tel Aviv, Israel
Teva Pharmaceuticals is a pharmaceutical company tShow more...hat develops generic and innovative medicines.
HQ: Tel Aviv, Tel Aviv, Israel
Specialized In: Pharmaceuticals, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Feb 12, 2024
Founded Date: 1901
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NYSE:TEVA
Operating Status: Active
Main email format: sarah.smith@tevapharm.com (58.3%)
-
Rob Koremans
President and CEO, Global Specialty Medicines
r*********s@tevapharm.com
-
Anthony Dombrowski Cmr
Neurology Account Specialist
a*********r@tevapharm.com
-
Joost Cohen Tervaert
Advisory Board Member at Sanara Ventures
j************t@tevapharm.com
-
Brandon Goodman
Associate Director, Commercial Training at Blueprint Medicines
b*****n@tevapharm.com
-
Jim Stice
Professor
j*m@tevapharm.com
-
Tim Buchanan
Sales Director
t*m@tevapharm.com
-
Alicia Roeschke
Customer Enablement Manager at Grainger
a****a@tevapharm.com
-
Unclassified inbox
jobs.europe@tevaeu.com

HQ: Basel, Basel-Stadt, Switzerland
Lonza Group supplies products and services to pharShow more...maceutical and agrochemical industries.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1897
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:LONN
Operating Status: Active
Main email format: sarah.smith@lonza.com (100.0%)
-
Alice Harrison
Global Technical Director
a************n@lonza.com
-
Thomas Stuenkel
t*************l@lonza.com
-
Elissa Goldstein
e**************n@lonza.com
-
Wolfgang Zimmerer
z***************g@lonza.com
-
General Inquiries
info@lonza.com
-
Admin Team
admin@lonza.com
-
General Inquiries
contact@lonza.com

HQ: Temple City, California, United States
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com

HQ: Northbrook, Illinois, United States
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com

HQ: Woonsocket, Rhode Island, United States
CVSPharmacy is a retail pharmacy that offers prescShow more...ription drugs, over-the-counter drugs, beauty products, and cosmetics.
HQ: Woonsocket, Rhode Island, United States
Specialized In: Consumer Goods & FMCG, Healthcare & Medical, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 12, 2024
Founded Date: 1963
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@cvs.com (81.8%)

HQ: London, England, United Kingdom
An executive agency of the Department of Health, eShow more...xists to enhance and improve the health of millions of people every day.
HQ: London, England, United Kingdom
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 29, 2023
Founded Date: Jan 1, 2003
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Investor Type: Government Office
Main email format: sarah.smith@gov.uk (100.0%)

HQ: Durham, North Carolina, United States
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
HQ: Durham, North Carolina, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com

HQ: Tarrytown, New York, United States
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
HQ: Tarrytown, New York, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
madison.lee@regeneron.com
-
General Inquiries
info@regeneron.com

HQ: Palo Alto, California, United States
Jazz Pharmaceuticals is a specialty pharmaceuticalShow more... company that identifies, develops and commercializes innovative treatments.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active
Main email format: sarah.smith@jazzpharma.com (100.0%)
-
Bruce Cozadd
Chief Executive Officer
b**********d@jazzpharma.com
-
Todd Johnson
t**********n@jazzpharma.com
-
Robert Fell
r*********l@jazzpharma.com
-
Temire Bobegbe
t************e@jazzpharma.com
-
General Inquiries
investorinfo@jazzpharma.com
-
General Inquiries
contact@jazzpharma.com

HQ: Eagan, Minnesota, United States
Prime Therapeutics is an independent pharmacy beneShow more...fit manager that primarily serves Blue Cross Blue Shield plans
HQ: Eagan, Minnesota, United States
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Last Investment Activity: Jun 10, 2024
Founded Date: 1990
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@primetherapeutics.com (77.8%)
-
Mostafa Kamal
Chief Executive Officer and President
m***********l@primetherapeutics.com
T***************************************************************************************************************m
-
Cameron M Kracke
c*****e@primetherapeutics.com
-
Unclassified inbox
RxNetworksDept@primetherapeutics.com

HQ: San Diego, California, United States
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com

HQ: Mumbai, Maharashtra, India
Cipla is a drug manufacturing company that focusesShow more... on a variety of pharmaceutical products.
HQ: Mumbai, Maharashtra, India
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Jul 28, 2024
Founded Date: 1935
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NSE:CIPLA
Operating Status: Active
Main email format: sarah.smith@cipla.com (90.0%)
-
Samina Vaziralli
Global Head - Strategy & New Ventures
s****a@cipla.com
-
Satyen Manikani
s*************i@cipla.com
-
General Inquiries
contactus@cipla.com
-
Unclassified inbox
Cipla.cs@cipla.com
-
General Inquiries
Contact@cipla.com
-
Unclassified inbox
drugsafety@cipla.com

HQ: Boston, Massachusetts, United States
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
HQ: Boston, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com

HQ: New York, New York, United States
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
Main email format: ssmith@loxooncology.com (87.5%)
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com

HQ: Madison, Wisconsin, United States
Allergan is a global pharmaceutical company.
HQ: Madison, Wisconsin, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals, Universities & Colleges
Acquired by: AbbVie
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 13, 2024
Founded Date: 1948
Company Type: For Profit
Stock Symbol: NYSE:AGN
Operating Status: Active
-
George Saltzberg
s**************e@allergan.com
-
Sharon DeFeo
defeo_sharon@allergan.com
-
General Inquiries
info@allergan.com

HQ: Charlotte, North Carolina, United States
Albemarle is a specialty chemical company focused Show more...on lithium, bromine, and refining catalysts.
HQ: Charlotte, North Carolina, United States
Specialized In: Manufacturing & Industrial, Construction Companies, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:ALB
Operating Status: Active
Main email format: sarah.smith@albemarle.com (100.0%)
-
Tamaria Lynch
Vice President Finance
t***********h@albemarle.com
-
Sales Department
albsales@albemarle.com

HQ: Bothell, Washington, United States
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
HQ: Bothell, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
Main email format: ssmith@seagen.com (83.3%)
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
General Inquiries
contact@seagen.com

HQ: Albany, New York, United States
“Albany Molecular Research Inc. provides scientifiShow more...c services, products and technologies that improve quality of life while delivering
HQ: Albany, New York, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active
Main email format: sarah.smith@amriglobal.com (100.0%)
-
Steven Pawlows
Senior Manager
s************s@amriglobal.com
-
Ikia Pwalther
Senior Director Business Development
i***********r@amriglobal.com
-
General Inquiries
InvestorInfo@amriglobal.com
-
Unclassified inbox
patty.eisenhaur@amriglobal.com
-
Unclassified inbox
seena.sankar@amriglobal.com

HQ: San Diego, California, United States
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com

HQ: Hørsholm, Hovedstaden, Denmark
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 27, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com

HQ: Castres-gironde, Aquitaine, France
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com

HQ: Saint-prex, Vaud, Switzerland
Ferring is a biopharmaceutical company that develoShow more...ps reproductive medicine for healthacare sectors.
HQ: Saint-prex, Vaud, Switzerland
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Debt Financing
Last Investment Activity: Jan 16, 2024
Founded Date: 1950
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ferring.com (100.0%)
-
General Inquiries
info@ferring.com
-
Admin Team
admin@ferring.com
-
Investor Relations
investor@ferring.com
-
General Inquiries
contact@ferring.com
-
Sales Department
sales@ferring.com

HQ: Columbus, Ohio, United States
Battelle Memorial Institute is a nonprofit researcShow more...h and development organization.
HQ: Columbus, Ohio, United States
Specialized In: Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 17, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: Non-profit
Operating Status: Active
Main email format: smiths@battelle.org (100.0%)
-
Cassandra Manos
Senior Contracts Manager
m*************a@bah.com
-
David White
Chief Information Officer
h*****l@battelle.org
-
Unclassified inbox
solutions@battelle.org

HQ: Pittsburgh, Pennsylvania, United States
Giant Eagle is a national supermarket chain with sShow more...ome of their own brands of products.
HQ: Pittsburgh, Pennsylvania, United States
Specialized In: Technology & Software, Food Delivery, Pharmaceuticals, E-commerce & Retail
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 12, 2024
Founded Date: 1931
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@gianteagle.com (100.0%)
-
Gary Hay
Chief Technology Officer
g******y@gianteagle.com
-
Unclassified inbox
gianteaglerx@mscripts.com

HQ: Burlington, Massachusetts, United States
inVentiv Health offers clinical and commercial proShow more...fessional services to help biopharmaceutical companies streamline their processes.
HQ: Burlington, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Jan 11, 2018
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Operating Status: Closed
Main email format: sarah.smith@inventivhealth.com (100.0%)
-
Thomas Carlo Maria Topini
thomas.topini@inventivhealth.com
-
General Inquiries
info@inventivhealth.com

HQ: Cambridge, Massachusetts, United States
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
Main email format: sarah.smith@genzyme.com (100.0%)
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
louise.harney@genzyme.com
-
General Inquiries
info@genzyme.com

HQ: Richmond, Virginia, United States
Indivior is a specialty pharmaceuticals business.
HQ: Richmond, Virginia, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 21, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:INDV
Operating Status: Active
Main email format: sarah.smith@indivior.com (100.0%)

HQ: Castres-gironde, Aquitaine, France
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com

HQ: Hørsholm, Hovedstaden, Denmark
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Mar 4, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com

HQ: Göttingen, Niedersachsen, Germany
Sartorius helps its customers to develop and manufShow more...acture biotech medicines reliably, quickly, and economically.
HQ: Göttingen, Niedersachsen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active
Main email format: sarah.smith@sartorius.com (100.0%)
-
Joachim Kreuzburg
Chairman of the Executive Board and CEO
j***************g@sartorius.com
-
General Inquiries
info@sartorius.com
-
Admin Team
admin@sartorius.com
-
General Inquiries
info@sartorius-stedim.com

HQ: Cambridge, Cambridgeshire, United Kingdom
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com

HQ: Cambridge, Massachusetts, United States
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
Main email format: ssmith@cullinanoncology.com (100.0%)

HQ: Shanghai, Shanghai, China
Fosun Pharma is a pharmaceutical company.
HQ: Shanghai, Shanghai, China
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 11
Company Type: For Profit
Stock Symbol: HKG:2196
Operating Status: Active
Investor Type: Venture Capital
Main email format: smiths@fosunpharma.com (83.3%)
-
Alex Zhu
Executive Director
z**a@fosunpharma.com
-
Zhu Xi
z*u@fosunpharma.com
-
Mike Xu
Co-President
x*m@fosunpharma.com
-
Investor Relations
ir@fosunpharma.com
-
Unclassified inbox
info.usa@fosunpharma.com
-
Unclassified inbox
fosunpharma@wsfg.hk
-
Unclassified inbox
int@fosunpharma.com
-
Unclassified inbox
LastF@fosunpharma.com
-
Unclassified inbox
lianzhengdc@fosunpharma.com

HQ: Gurgaon, Haryana, India
1mg is an online pharmacy network platform and genShow more...eric medicine engine.
HQ: Gurgaon, Haryana, India
Specialized In: E-commerce & Retail, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 51-100
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 8, 2022
Founded Date: Feb 3, 2015
Company Type: For Profit
Operating Status: Active
Main email format: sarah@1mg.com (33.3%)
-
Prashant Tandon
CEO & Co-Founder
p******t@1mg.com
-
Gaurav Agarwal
Co-Founder & CTO
g*****a@1mg.com
*********4
-
Ravish Aanand
r***********d@1mg.com
-
Mike McGarr
Senior Engineering Leader, Desktop Foundations at Slack
mm@1mg.com
-
Tanmay Saksena
Chief Operating Officer
t****y@1mg.com
-
Arpit Sarin
Head- Marketplace Operations,Head of Business Insights- Retail
a*********n@1mg.com
-
General Inquiries
info@1mg.com
-
General Inquiries
hello@1mg.com
-
Customer Service
support@1mg.com
-
Sales Department
sales@1mg.com
-
Legal Department
legal@1mg.com
-
Unclassified inbox
care@1mg.com

HQ: Novato, California, United States
Ultragenyx Pharmaceutical focuses on the developmeShow more...nt of various products for the treatment of rare and ultra-rare diseases.
HQ: Novato, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 26, 2024
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
Main email format: ssmith@ultragenyx.com (83.3%)
-
John Klock
Founder
j**n@ultragenyx.com
-
Xiaohui Lu
Senior Research Scientist
x*u@ultragenyx.com
-
General Inquiries
info@ultragenyx.com
-
Unclassified inbox
trialrecruitment@ultragenyx.com
-
Unclassified inbox
MCorley@ultragenyx.com

HQ: Stamford, Connecticut, United States
Purdue Pharma develops, manufactures, and markets Show more...medications and consumer health products.
HQ: Stamford, Connecticut, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Dec 4, 2023
Founded Date: 1892
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@purduepharma.com (50.0%)
-
Bill Watson
w****n@purduepharma.com
-
Heather Jordan
Industry Account Executive at SAP
j****n@purduepharma.com
-
Stephen Rayda
Global Head of Infrastructure and Client Services at Purdue Pharma L.P.
s***********a@purduepharma.com
-
Donna Krizik
Experienced Marketing Director | SEO | B2B Marketer | Content Strategist
dk@purduepharma.com
-
Marc Kesselman
S.V.P. & General Counsel
m************n@purduepharma.com
-
General Inquiries
purduemedInfo@pharma.com

HQ: Cincinnati, Ohio, United States
Medpace, Inc., a clinical research organization, pShow more...rovides clinical development services for pharmaceutical and biotechnology
HQ: Cincinnati, Ohio, United States
Specialized In: Biotechnology, Pharmaceuticals
Acquired by: Cinven
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 12, 2024
Founded Date: 1992
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MEDP
Operating Status: Active
Main email format: s.smith@medpace.com (100.0%)

HQ: Dublin, Dublin, Ireland
Alkermes is a biotechnology company that develops,Show more... manufactures and commercializes medicines for the treatment of chronic diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 22, 2024
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ALKS
Operating Status: Active
Main email format: sarah.smith@alkermes.com (100.0%)

HQ: Morrisville, North Carolina, United States
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com

HQ: South San Francisco, California, United States
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com

HQ: New York, New York, United States
Owkin is an AI precision medicine company with a vShow more...ision to find the right drug for every patient.
HQ: New York, New York, United States
Specialized In: AI & Machine Learning, Pharmaceuticals, Healthcare SaaS, SaaS
Business Type: Private
Employees: 251-500
Rounds: Series B
Last Investment Activity: Mar 26, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@owkin.com (50.0%)
-
Thomas Clozel
Co-Founder & CEO
tc@owkin.com
-
Thomas Clozel
Co-Founder & CEO
t***********l@owkin.com
-
Gilles Wainrib
Founder
gw@owkin.com
-
Darius Meadon
Chief Marketing Officer
d***********n@owkin.com
-
Antonia Twiston-Davies
a************r@owkin.com
-
General Inquiries
hello@owkin.com
-
Customer Service
support@owkin.com
-
General Inquiries
contact@owkin.com
-
Sales Department
sales@owkin.com
-
Legal Department
legal@owkin.com

HQ: Exton, Pennsylvania, United States
West Pharmaceutical Services is a manufacturer of Show more...technologically advanced containment and delivery systems for injectable medicines.
HQ: Exton, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jun 21, 2024
Founded Date: 1923
Company Type: For Profit
Stock Symbol: NYSE:WST
Operating Status: Active
Main email format: sarah.smith@westpharma.com (100.0%)
-
Atul Patel
Vice President, Devices & Delivery Systems
a********l@westpharma.com
-
Preety Lall
p*********l@westpharma.com
-
Unclassified inbox
John.Sweeney@westpharma.com
-
Unclassified inbox
lynn.lundy@westpharma.com
-
Unclassified inbox
Kimberly.MacKay@westpharma.com
-
Customer Service
westpharmaceuticalservices@westpharma.com

HQ: South San Francisco, California, United States
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
Main email format: ssmith@cytokinetics.com (100.0%)
-
Tina Controy
t******y@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com

HQ: Mumbai, Maharashtra, India
Piramal Group is a diversified conglomerate with oShow more...perational presence in pharma, financial services, information management and real estate.
HQ: Mumbai, Maharashtra, India
Specialized In: Finance & Banking, Technology & Software, Pharmaceuticals, Real Estate Agencies & Brokers
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 13, 2024
Founded Date: Dec 2, 1992
Company Type: For Profit
Stock Symbol: NSE:PEL
Operating Status: Active
Main email format: sarah.smith@piramal.com (100.0%)
-
Unclassified inbox
customercare@piramal.com
-
Unclassified inbox
nodal.officer@piramal.com
-
Unclassified inbox
medical.information@piramal.com
-
Unclassified inbox
contact.us@piramal.com
-
Unclassified inbox
corporate.communication@piramal.com

HQ: Woodcliff Lake, New Jersey, United States
Eagle Pharmaceuticals is a company focused on deveShow more...loping and commercializing injectable products in the critical care and oncology areas.
HQ: Woodcliff Lake, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Public
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: May 22, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NASDAQ:EGRX
Operating Status: Active
Main email format: ssmith@eagleus.com (100.0%)
-
Jorma Lalla
Vice President
j****a@eagleus.com
-
Daniel Maher
d****r@eagleus.com
-
General Inquiries
info@eagleus.com
-
Unclassified inbox
aelgohail@eagleus.com
-
Unclassified inbox
jlarocca@eagleus.com
-
Unclassified inbox
egrx@openboard.info

HQ: Paris, Ile-de-France, France
InVivo helps agriculture cooperation regain their Show more...rightful place in the global food value chain.
HQ: Paris, Ile-de-France, France
Specialized In: AgTech, Pharmaceuticals, Healthcare & Medical
Business Type: Private
Employees: 5001-10000
Rounds: Private Equity
Last Investment Activity: Mar 5, 2024
Founded Date: 1945
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@invivo-group.com (100.0%)
-
Maha Fournier
Group Chief Financial and Operating Officer
m*******r@invivo-group.com
-
Romain Affanni
r******i@invivo-group.com
-
Delphine CAMUS
d****s@invivo-group.com
-
General Inquiries
info@invivo-group.com
-
Admin Team
admin@invivo-group.com
-
Customer Service
support@invivo-group.com
-
General Inquiries
contact@invivo-group.com
-
Sales Department
sales@invivo-group.com

HQ: Palo Alto, California, United States
BridgeBio focuses on the development and commerciaShow more...lization of precision medicines for various genetic diseases and cancers.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 2015
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:BBIO
Operating Status: Active
Main email format: ssmith@bridgebio.com (80.0%)
-
Neil Kumar
Co-Founder & CEO
n********r@bridgebio.com
-
Brian Stephenson
b*********n@bridgebio.com
-
General Inquiries
info@bridgebio.com
-
Customer Service
support@bridgebio.com
-
Management Department
manager@bridgebio.com
-
General Inquiries
contact@bridgebio.com
-
Sales Department
sales@bridgebio.com

HQ: Suresnes, Ile-de-France, France
Servier is an pharmaceutical company governed by aShow more... non-profit foundation.
HQ: Suresnes, Ile-de-France, France
Specialized In: Healthcare & Medical, Medical Devices, Pharmaceuticals
Acquired by: AIvarix
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 7, 2024
Founded Date: 1954
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@servier.com (100.0%)

HQ: Smiths Falls, Ontario, Canada
Canopy Growth is a cannabis consumer product compaShow more...ny that manufactures medical cannabis to improve lives.
HQ: Smiths Falls, Ontario, Canada
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 2014
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TSX:WEED
Operating Status: Active
Main email format: sarah.smith@canopygrowth.com (100.0%)
-
Bruce Linton
Founder
b**********n@canopygrowth.com
-
Christelle Gedeon
Partner
c***************n@canopygrowth.com
-
Unclassified inbox
invest@canopygrowth.com

HQ: Wilmington, Delaware, United States
Incyte is a drug discovery and development companyShow more... which hopes to build a proprietary product pipeline of novel small molecule drugs.
HQ: Wilmington, Delaware, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 16, 2024
Founded Date: 1991
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:INCY
Operating Status: Active
Main email format: ssmith@incyte.com (100.0%)
-
John Janik
Vice President Clinical Research
j****k@incyte.com
-
Abdelhak AMARA KORBA
a****a@incyte.com
-
Allison Kozeny
a*****y@incyte.com
-
Nicola Stephens
Sales Representative
n*******s@incyte.com
-
General Inquiries
medinfo@incyte.com

HQ: Fort Myers, Florida, United States
NeoGenomics is a cancer reference laboratory that Show more...provides cancer testing and partnership programs to pathologists and oncologists.
HQ: Fort Myers, Florida, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
Main email format: ssmith@neogenomics.com (100.0%)
-
Unclassified inbox
aimee.bui@neogenomics.com
-
Human Resources Team
HR@neogenomics.com
-
Human Resources Team
hr@neogenomics.com

HQ: Hamburg, Hamburg, Germany
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
HQ: Hamburg, Hamburg, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
Main email format: sarah.smith@evotec.com (75.0%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
General Inquiries
info@evotec.com

HQ: Osaka-shi, Osaka, Japan
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
HQ: Osaka-shi, Osaka, Japan
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
Main email format: ssmith@shionogi.com (100.0%)
-
Sol Yates
s****s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp

HQ: San Diego, California, United States
Ligand is a biopharmaceutical company focused on dShow more...eveloping or acquiring technologies that help pharmaceutical companies.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: Sep 1, 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:LGND
Operating Status: Active
Main email format: ssmith@ligand.com (66.7%)
-
John L. Higgins
CEO
j******s@ligand.com
-
Paul Hadden
Managing Director
p*****n@ligand.com
-
General Inquiries
info@ligand.com
-
Admin Team
admin@ligand.com
-
General Inquiries
contact@ligand.com
-
Career Opportunities
jobs@ligand.com

HQ: Carlsbad, California, United States
Lineage Cell Therapeutics is a clinical-stage biotShow more...echnology company developing novel cellular therapies to treat unmet medical needs.
HQ: Carlsbad, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Coaching & Consulting, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 6, 2024
Founded Date: Jan 1, 1990
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TLV:BTX
Operating Status: Active
Main email format: ssmith@lineagecell.com (100.0%)
-
Jill Howe
Chief Financial Officer
j***e@lineagecell.com
-
General Inquiries
info@lineagecell.com
-
General Inquiries
contact@lineagecell.com
-
Legal Department
legal@lineagecell.com

HQ: Suzhou, Jiangsu, China
Ascentage is a clinical-stage biopharmaceutical coShow more...mpany that develops drugs for the treatment of cancer.
HQ: Suzhou, Jiangsu, China
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 101-250
Rounds: Series C
Last Investment Activity: Jan 2, 2024
Founded Date: 2009
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@ascentagepharma.com (66.7%)
-
Unclassified inbox
PR@ascentagepharma.com
-
Unclassified inbox
bd@ascentagepharma.com
-
Unclassified inbox
cyang@ascentagepharma.com

HQ: Palo Alto, California, United States
Scilex Pharmaceuticals is an emerging pharmaceuticShow more...al company focused on acquiring and commercializing late-stage prescription products.
HQ: Palo Alto, California, United States
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Last Investment Activity: Mar 2, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SCLX
Operating Status: Active
Main email format: ssmith@scilexholding.com (100.0%)
-
Jaisim Shah
CEO & President, Director,CEO & Director, Scilex Holding
j***h@scilexholding.com
-
General Inquiries
info@scilexholding.com
-
General Inquiries
info@scilexpharma.com

HQ: Malvern, Pennsylvania, United States
Par Pharmaceutical develops, manufactures, and marShow more...kets innovative and cost-effective generic pharmaceutical products.
HQ: Malvern, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Jun 28, 2019
Founded Date: 1978
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@parpharm.com (66.7%)
-
Unclassified inbox
cs.formulations@parpharm.com
-
Unclassified inbox
Thomas.Haughey@parpharm.com
-
Unclassified inbox
john.smith@parpharm.com

HQ: Miami, Florida, United States
Opko Health engages in the discovery and developmeShow more...nt of novel and proprietary technologies for pharmaceuticals and diagnostics.
HQ: Miami, Florida, United States
Specialized In: Biotechnology, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 5, 2024
Founded Date: 2005
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:OPK
Operating Status: Active
Main email format: ssmith@opko.com (100.0%)
-
Charles Bishop
CEO, Renal Division
c*****p@opko.com
-
General Inquiries
contact@opko.com

HQ: Rochester, New York, United States
AeroSafe Global develops aerogels used in various Show more...transport, biomedical, pharmaceutical, and other temperature-sensitive products.
HQ: Rochester, New York, United States
Specialized In: Pharmaceuticals, Manufacturing & Industrial
Business Type: Private
Employees: 51-100
Rounds: Private Equity
Last Investment Activity: Nov 28, 2023
Founded Date: 1995
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@aerosafeglobal.com (100.0%)
-
General Inquiries
info@aerosafeglobal.com
-
Customer Service
support@aerosafeglobal.com
-
General Inquiries
info@americanaerogel.com

HQ: Seoul, Seoul-t'ukpyolsi, South Korea
LG Chem is a chemical company that provides innovaShow more...tive materials and solutions for its customers.
HQ: Seoul, Seoul-t'ukpyolsi, South Korea
Specialized In: Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 28, 2024
Founded Date: 1947
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: sarahs@lgchem.com (100.0%)
-
Unclassified inbox
contact.cbl@lgchem.com
-
Unclassified inbox
meejungkim@lgchem.com
-
Unclassified inbox
samueljang@lgchem.com

HQ: Dublin, Dublin, Ireland
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
Main email format: ssmith@shire.com (100.0%)
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com

HQ: Boulogne-billancourt, Ile-de-France, France
Ipsen is a global specialty-driven biopharmaceuticShow more...al company focused on innovation and specialty care.
HQ: Boulogne-billancourt, Ile-de-France, France
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1929
Number of Exits: 5
Company Type: For Profit
Stock Symbol: EPA:IPN
Operating Status: Active
Main email format: sarah.smith@ipsen.com (100.0%)
-
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
s**************i@ipsen.com
-
Susan Tinney
s**********y@ipsen.com
-
Karen Hummel
Executive Director, National Health Systems, Medical Affairs
k**********l@ipsen.com
-
Helen Hsu
h*******u@ipsen.com
-
Unclassified inbox
Clinical.trials@ipsen.com
-
Unclassified inbox
corporate.communications@ipsen.com
-
Unclassified inbox
qualitycomplaints.russia.cis@ipsen.com
-
Unclassified inbox
ipsenepe@ipsen.com
-
Unclassified inbox
medical.information.russia.cis@ipsen.com
-
Unclassified inbox
medinfo.uk-ie@ipsen.com
-
Unclassified inbox
contact.web@ipsen.com

HQ: Silver Spring, Maryland, United States
United Therapeutics Corporation is a biotechnologyShow more... company focused on the development and commercialization of unique products.
HQ: Silver Spring, Maryland, United States
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 28, 2024
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:UTHR
Operating Status: Active

HQ: Seattle, Washington, United States
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active

HQ: San Diego, California, United States
Rakuten Medical is a biotechnology company that deShow more...velops precision, cell-targeting investigational therapies.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Mar 26, 2024
Founded Date: 2010
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@rakuten-med.com (100.0%)
-
Unclassified inbox
info.tw@rakuten-med.com
-
Unclassified inbox
j.d@rakuten-med.com
-
General Inquiries
info@rakuten-med.com

HQ: Mechelen-bovelingen, Limburg, Belgium
Galapagos is a clinical-stage biotechnology companShow more...y, specialized in the discovery and development of small molecule medicines with novel.
HQ: Mechelen-bovelingen, Limburg, Belgium
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 25, 2024
Founded Date: 1999
Company Type: For Profit
Stock Symbol: VIE:GLPG
Operating Status: Active

HQ: New Delhi, Delhi, India
Mankind Pharma is a pharmaceutical company that deShow more...velops, commercializes, and delivers medicines for urgent medical needs.
HQ: New Delhi, Delhi, India
Specialized In: Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Secondary Market
Last Investment Activity: Mar 11, 2024
Founded Date: 1995
Company Type: For Profit
Operating Status: Active

HQ: Seattle, Washington, United States
Fred Hutchinson Cancer Research Center provides seShow more...rvices for the prevention, early detection, and treatment of cancer and other diseases.
HQ: Seattle, Washington, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Health Diagnostics, Travel & Hospitality, Hospitals & Clinics, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Aug 9, 2023
Founded Date: 1975
Company Type: For Profit
Operating Status: Active
-
k*****e@fredhutch.org
-
s****m@fredhutch.org
***********
-
a*************n@fredhutch.org
-
Unclassified inbox
communications@fredhutch.org

HQ: Morristown, New Jersey, United States
Alvogen is a manufacturer of pharmaceutical products.
HQ: Morristown, New Jersey, United States
Specialized In: Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Feb 3, 2023
Founded Date: 2009
Number of Exits: 2
Company Type: For Profit
Operating Status: Active

HQ: New York, New York, United States
Roivant Sciences is a biopharmaceutical company foShow more...cused on the development of medicines and healthcare technologies to patients.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: May 2014
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ROIV
Operating Status: Active

HQ: Paris, Ile-de-France, France
Sanofi is a healthcare company that provides treatShow more...ments and the protection of life-saving vaccines.
HQ: Paris, Ile-de-France, France
Specialized In: Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 21, 2024
Founded Date: 1973
Number of Exits: 12
Company Type: For Profit
Stock Symbol: NYSE:SNY
Operating Status: Active
Main email format: sarah.smith@sanofi.com (66.7%)
-
Patricia Roselle
Global Head, Patient Network Management
p*************e@sanofi.com
-
Guy Griebel
Senior Director Sanofi Genzyme Neuroscience
g*********l@sanofi.com
-
Anne Dulac-Gaume
Corporate Business Development - Director
a*************e@sanofi.com
-
Unclassified inbox
caio.inbox@sanofi.com
-
Customer Service
customersupport@sanofi.com

HQ: Pasadena, California, United States
Arrowhead Pharmaceuticals is a biotechnology compaShow more...ny that focuses on the development of medicine to treat diseases with a genetic origin.
HQ: Pasadena, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Technology & Software, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 7, 2024
Founded Date: 1989
Company Type: For Profit
Stock Symbol: NASDAQ:ARWR
Operating Status: Active
Main email format: ssmith@arrowheadpharma.com (100.0%)
-
Bruce Given
Chief Operating Officer
b****n@arrowheadpharma.com
-
Matthew Cyr
Postbaccalaureate Fellow
m**r@arrowheadpharma.com
-
General Inquiries
info@arrowheadpharma.com
-
Legal Department
legal@arrowheadpharma.com
-
General Inquiries
info@arrowres.com

HQ: Paris, Ile-de-France, France
Unither Pharmaceuticals is a French manufacturer oShow more...f dosage forms for pharmaceutical laboratories and generic products.
HQ: Paris, Ile-de-France, France
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Acquired by: Ardian
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Jul 2, 2024
Founded Date: 1993
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@unither-pharma.com (100.0%)
-
Admin Team
admin@unither-pharma.com
-
General Inquiries
contact@unither-pharma.com
-
Unclassified inbox
unither@unither-pharma.com

HQ: London, England, United Kingdom
BTG is a global healthcare company focused on InteShow more...rventional Medicine.
HQ: London, England, United Kingdom
Specialized In: Pharmaceuticals, Hospitals & Clinics, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jan 27, 2020
Founded Date: 1948
Number of Exits: 2
Company Type: For Profit
Operating Status: Closed
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.